Search
for
Sort by
Research 31–60 of 106
- A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania
- Alopecia associated with quetiapine
- Drug-induced changes in hair growth
- Drug-Induced Hair Loss and Hair Growth
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research
- Drug-Induced Skin, Nail and Hair Disorders
- Drug Reactions Affecting Hair: Diagnosis
- TREATMENT OF ALOPECIA AREATA
- Adverse Cutaneous Reactions to Mood Stabilizers
- Systemic treatments for alopecia areata: A systematic review
- Drug-Induced Hair Disorders
- The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs
- Psychotropic Medication and Drug-Related Alopecia
- Trichotillomania: Clinical Aspects and Treatment Strategies *
- Psychodermatology
- Pediatric Psychocutaneous Disorders
- Psychotrichology: psychosomatic aspects of hair diseases
- Relating neurosteroid modulation of inhibitory neurotransmission to behaviour
- Anticonvulsant-Induced Cutaneous Reactions
- Potential Medical Uses of Cannabigerol: A Brief Overview
- Update on the Treatment of Alopecia Areata
- A machine learning and network framework to discover new indications for small molecules
- Psychotropic Medications and the Skin
- Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology
- Role of skin enzymes in metabolism of topical drugs
- Involvement of the central hypothalamic-pituitary-adrenal axis in hair growth and melanogenesis among different mouse strains
- Adverse cutaneous effects of psychotropic medications
- Update on psychodermatological disorders
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases